Please use the following link to access our final thoughts on ROL Q2'22 as well as our decision to discontinue ongoing research coverage of the name.
In this issue of "Short Shrift," we provide updates on names under our research coverage throughout the 2Q22 earnings season. Please use the following link to access our thoughts on reports from: AOS, CPA, ROL, TRN, LAD, and GPK
Please use the following link to download our report with updated thoughts on names under our coverage: AOS, CPA, ROL, FLS, and TRN.
Please use the following link to download our initiation report for Rollins (NYSE:ROL - $31.46)